Centaurus Financial’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,732
| Closed | -$23K | – | 919 |
|
|
2022
Q4 | $23K | Hold |
20,732
| – | – | ﹤0.01% | 832 |
|
|
2022
Q3 | $34K | Sell |
20,732
-215
| -1% | -$353 | ﹤0.01% | 841 |
|
|
2022
Q2 | $27K | Sell |
20,947
-167
| -0.8% | -$215 | ﹤0.01% | 825 |
|
|
2022
Q1 | $34K | Buy |
+21,114
| New | +$34K | ﹤0.01% | 880 |
|
|
2021
Q4 | – | Sell |
-22,614
| Closed | -$88K | – | 937 |
|
|
2021
Q3 | $88K | Buy |
22,614
+7,000
| +45% | +$27.2K | 0.01% | 871 |
|
|
2021
Q2 | $50K | Hold |
15,614
| – | – | ﹤0.01% | 880 |
|
|
2021
Q1 | $34K | Hold |
15,614
| – | – | ﹤0.01% | 803 |
|
|
2020
Q4 | $35K | Hold |
15,614
| – | – | ﹤0.01% | 767 |
|
|
2020
Q3 | $42K | Hold |
15,614
| – | – | 0.01% | 636 |
|
|
2020
Q2 | $48K | Buy |
15,614
+413
| +3% | +$1.27K | 0.01% | 604 |
|
|
2020
Q1 | $30K | Sell |
15,201
-62
| -0.4% | -$122 | 0.01% | 516 |
|
|
2019
Q4 | $44K | Hold |
15,263
| – | – | 0.01% | 624 |
|
|
2019
Q3 | $56K | Sell |
15,263
-1,300
| -8% | -$4.77K | 0.01% | 439 |
|
|
2019
Q2 | $69K | Buy |
16,563
+16,481
| +20,099% | +$68.7K | 0.01% | 585 |
|
|
2019
Q1 | $16.1K | Buy |
+82
| New | +$16.1K | 0.09% | 188 |
|
|
2018
Q4 | – | Sell |
-10
| Closed | -$60 | – | 496 |
|
|
2018
Q3 | $60 | Sell |
10
-16,702
| -100% | -$100K | 0.01% | 530 |
|
|
2018
Q2 | $106K | Buy |
16,712
+6,712
| +67% | +$42.6K | 0.01% | 688 |
|
|
2018
Q1 | $47K | Hold |
10,000
| – | – | 0.01% | 452 |
|
|
2017
Q4 | $33K | Buy |
+10,000
| New | +$33K | 0.01% | 318 |
|